H Jaccard Ruedin
Affiliation: Swiss Federal Research Station
- Invasive meningococcal and pneumococcal disease in Switzerland: cost-utility analysis of different vaccine strategiesH Jaccard Ruedin
Epidemiology and Infectious Diseases, Swiss Federal Office of Public Health, 3003, Bern, Switzerland
Vaccine 21:4145-52. 2003..The strategy using three doses of MenC/PCV-9 would achieve the highest health benefit, with 440 quality-adjusted life years (QALYs) gained at costs of 34,000 per QALY...
- Epidemiology of meningococcal disease in Switzerland, 1999-2002H Jaccard Ruedin
Epidemiology and Infectious Diseases, Swiss Federal Office of Public Health, 3003 Bern, Switzerland
Eur J Clin Microbiol Infect Dis 23:517-22. 2004..However, when the introduction of a generalised vaccination against serogroup C meningococcal disease is discussed, the fluctuations in the number of vaccine-preventable deaths should receive greater attention...
- [Family practitioners in Switzerland by 2030: which roles for medical task delegation?]Hélène Jaccard Ruedin
Observatoire suisse de la santé, Neuchatel, Suisse
Cah Sociol Demogr Med 49:205-25. 2009..On the supply side, a full scale implementation of task delegation may partially reduce that gap (minus 2 millions). On the demand side, improved health status may bring in a larger decrease in the needs for visits (minus 4 million)...